Gadoteridol

Records for this ingredient, by country (identity only).

ATC V08CA04 · 8 markets · 28 records

Gadoteridol 8 markets · 28 records Forms
Filters

JP 8 records · 6 shown of 6 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

AU 6 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 279.3 mg/mL per mL / per unit basis not statedinjectionPROHANCE gadoteridol 2793mg/10mL injection syringePROHANCE gadoteridol 2793mg/10mL injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

GB 5 records · 4 shown of 4 Source NHSBSA dm+d · Data as of 2026-10-19

US 2 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 279.3 mg per mL / per unit basis not statedinjectionProHanceManufacturer: Slate Run Pharmaceuticals, …

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

FR 2 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 279.3 mg/1 mLinjectionPROHANCE 0,5 mmol/mL, solution injectablePROHANCE 0,5 mmol/mL, solution injectable en seringue pré-remplie also in ES

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 279.3 mg per mL / per unit basis not statedliquidProHance

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.